Group items tagged

Researchers have made dramatic inroads into the study of polygenic and other complex human diseases, due in large part to knowledge of the human genome sequence, the generation of widespread markers of genetic variation, and the development of new technologies that allow investigators to associate disease phenotypes with genetic loci. Although polygenic diseases are more common than single-gene disorders, studies of monogenic diseases provide an invaluable opportunity to learn about underlying molecular mechanisms, thereby contributing a great deal to our understanding of all forms of genetic disease.

In this lesson, students explore some of the risks and benefits of gene-based medicine. They look at concerns related to genetic testing (which looks for particular genetic variations) and personal genome sequencing (which sequences the entire genome of an individual). Through videos and discussions, students learn about existing technologies for genetic testing and therapies. They also explore matters such as the emotional consequences of genetic testing, discrimination, and privacy issues. In small groups, students discuss scenarios and then share and analyze related opinions and concerns.

This directed case study was developed in order to present genomic data to students, allow them to interpret the impact of genetic variations on phenotype, and to explore precision medicine. Students are introduced to "Josie," a college sophomore who decides to have her genome sequenced after learning about genome-wide association studies (GWAS) in class. As students work  through the case, they learn about the different technologies that can be used in GWAS studies and interpret Josie's results for a subset of genetic markers that affect a range of traits from pharmacogenetics to disease risk alleles and non-pathogenic traits. Students are confronted with ethical issues such as duty to inform, actionable results, and variants of unknown significance (VUS). Students are also asked to reflect on their feelings about getting genomic testing for themselves. An optional activity for advanced students (included in the teaching notes) involves using the Gene database at NCBI to explore variants of the CYP2C9 gene. The case study is appropriate for use in undergraduate genetics or molecular biology classrooms.

This case study is centered on a real scenario from 2013 in which the Kickstarter fundraising platform included a fundraising proposal from a group wanting to use synthetic biology to make glowing plants. The proposal raised controversy because the Glowing Plant group offered to give away their genetically-modified glowing plant product to investors.  Kickstarter subsequently changed its policy to prevent use of genetically modified organisms as rewards or incentives to investors. This case study was developed for a college first-year seminar focused on the ethics of synthetic biology, and was introduced during the first week of the semester. The case uses the jigsaw teaching method to introduce students both to the mechanics of synthetic biology and to questions about how we should distribute the benefits and burdens associated with new or emerging technologies. It could be adapted for courses in introductory college biology, genetics or bioethics.

Federal regulators on Thursday approved a genetically engineered salmon as fit for consumption, making it the first genetically altered animal to be cleared for American supermarkets and dinner tables. The approval by the Food and Drug Administration caps a long struggle for AquaBounty Technologies, a small company that first approached the F.D.A. about approval in the 1990s. The agency made its initial determination that the fish would be safe to eat and for the environment more than five years ago.

The STAR-G Project has put together fact sheets about disorders commonly screened for by newborn screening. The fact sheets were written specifically for families that have received an initial diagnosis of one of the disorders and want to know more general information. They address issues and answer questions that are of particular concern to parents. Each fact sheet was written by a genetic counselor and reviewed by metabolic and genetic specialists.

DNA is an interactive Web site where students can learn about DNA and its structure and function, the scientific history of its discovery and its development into a powerful tool in biology, technology, and medicine, and about the Human Genome Project, genetic engineering, and some of the implications and ethical issues surrounding genetic technology.

"Bioethics is the study of ethical, legal, and social issues raised by advances in biology and medicine. Bioethics addresses a range of controversial topics, including privacy and fairness in the use of genetic information, integration of new technologies, such as genetic testing, into medical practice, and the design and conduct of research studies and clinical trials.  "

A kind of salmon that's been genetically modified so that it grows faster may be on the way to a supermarket near you. The Food and Drug Administration approved the fish on Thursday - a decision that environmental and food-safety groups are vowing to fight. This new kind of fast-growing salmon was actually created 25 years ago by Massachusetts-based AquaBounty Technologies. A new gene was inserted into fertilized salmon eggs - it boosted production of a fish growth hormone. The result: a fish that grows twice as fast as its conventional, farm-raised counterpart.

Officials in Panama have ruled that AquaBounty Technologies' has been operating in violation of environmental regulations as it experiments with genetically engineered (GE) salmon in that country. In a decision that could challenge the U.S. Food and Drug Administration's (FDA) ongoing safety assessment of AquaBounty's GE salmon, Panamanian officials fined the company $9500. Food & Water Watch, Center for Food Safety and Friends of the Earth called on the FDA today to terminate its regulatory review and deny AquaBounty's pending regulatory application to sell the company's GE fish in the United States.

Séguin, a research scientist in forest genomics with the Canadian Forest Service, inserted bacterial DNA into spruces that effectively made them immune to spruce budworm, a pest that can chew needles off tens of millions of hectares of trees in a single outbreak. While there is controversy over genetic engineering, some scientists say it could also help fight climate change by creating trees that grow bigger, faster, resist disease and can even turn carbon into a stable white powder that falls to the ground - in other words, trees that would be better at pulling carbon from the atmosphere.

This animation depicts the CRISPR-Cas9 method for genome editing - a powerful new technology with many applications in biomedical research, including the potential to treat human genetic disease. Feng Zhang, a leader in the development of this technology, is a faculty member at MIT, an investigator at the McGovern Institute for Brain Research, and a core member of the Broad Institute. Further information can be found on Prof. Zhang's website at http://zlab.mit.edu .

Over the last decade, as DNA-sequencing technology has grown ever faster and cheaper, our understanding of the human genome has increased accordingly. Yet scientists have until recently remained largely ham-fisted when they've tried to directly modify genes in a living cell. Take sickle-cell anemia, for example. A debilitating and often deadly disease, it is caused by a mutation in just one of a patient's three billion DNA base pairs. Even though this genetic error is simple and well studied, researchers are helpless to correct it and halt its devastating effects.

Biologists at the Massachusetts Institute of Technology have created a genetically modified version of a common bacteria found in the gut that can sense the environment there and fight disease. And when this designer bacteria works, the proof is in the poop - glowing poop. (In this case, mouse poop.)

An international team led by Professor Itai YanaAi of the Technion-Israel Institute of Technology Department of Biology made the discovery after using an extraordinarily powerful technique known as CEL-Seq. CEL-Seq monitors individual cells for their gene activity (as detected via mRNA)-and they applied it across 10 different species, with CEL-Seq being applied to 70 embryos per species. In particular, they were interested in whether the animal classification of phylum-which separates animals into groups according to their body plans-is actually a useful tool for placing animals into groups, as well as what genetic attributes are the same and different between the different phyla.

college website

Geneticist Jennifer Doudna co-invented a groundbreaking new technology for editing genes, called CRISPR-Cas9. The tool allows scientists to make precise edits to DNA strands, which could lead to treatments for genetic diseases … but could also be used to create so-called "designer babies." Doudna reviews how CRISPR-Cas9 works - and asks the scientific community to pause and discuss the ethics of this new tool.

Human activities currently add about nine gigatons of carbon to the atmosphere yearly. Photosynthetic organisms on land and in the ocean absorb about five of those gigatons through the natural uptake of CO2, leaving to humans the task of dealing with the rest. But no matter how much carbon there is, capturing it and preventing it from reentering the atmosphere is an immense engineering challenge; even today's best technology is orders of magnitude less effective than photosynthesis at trapping atmospheric carbon.

The 1000 Genomes Project is an international collaboration to produce an extensive public catalog of human genetic variation, including SNPs and structural variants, and their haplotype contexts. This resource will support genome-wide association studies and other medical research studies. The genomes of about 2500 unidentified people from about 25 populations around the world will be sequenced using next-generation sequencing technologies. The results of the study will be freely and publicly accessible to researchers worldwide. Further information about the project is available in the About tab. Information about downloading, browsing or using the 1000 Genomes data is available in the Data tab.

In "Harvest of Fear," FRONTLINE and NOVA explore the intensifying debate over genetically-modified (gm) food crops. Interviewing scientists, farmers, biotech and food industry representatives, government regulators, and critics of biotechnology, this two-hour report presents both sides of the debate, exploring the risks and benefits, the hopes and fears, of this new technology.